Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medikaloka Hermina Tbk. (HEAL) vs Merck Tbk. (MERK) Price & Performance

Medikaloka Hermina Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Medikaloka Hermina Tbk. vs Merck Tbk. — how do they compare? Medikaloka Hermina Tbk. trades at Rp710 (market cap 10.83T, 12.37M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Medikaloka Hermina Tbk. is far larger — about 6.2× Merck Tbk.'s market cap, and Medikaloka Hermina Tbk. is more actively traded (12.37M versus 29.1K). Which is the better fit depends on your goals.

HEALMERK
Market Cap
10.83T1.75T
Volume
12.37M29.1K
Lot
123.75K291
Turnover
8.71B113.37M
Average Price
703.753,895.98
Value
8.71B113.37M
Indicative Equilibrium Price
7103,890
Indicative Equilibrium Volume
1.97K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HEAL
View details
MERK
View details

About Medikaloka Hermina Tbk.

PT Medikaloka Hermina Tbk (“the Company”) was established based on Notarial Deed of Imam Santoso, S.H., No. 5 dated May 7, 1999.

Read more on HEAL

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK